Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.56 |
| ▸ | FPR2 | P25090 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | ACACB | O00763 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MME | P08473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9819533 | 1.00 | LDHA (0.56) | LDHAFPR2PTGS1ALDH1A1MEN1 | |
| SCHEMBL9405347 | 1.00 | LDHA (0.56) | LDHAFPR2PTGS1ALDH1A1MEN1 | |
| SCHEMBL25471843 | 0.93 | ITGB3 (0.49) | LDHAFPR2PTGS1ALDH1A1TSHR | |
| SCHEMBL2516039 | 0.92 | LDHA (0.66) | LDHAFPR2ALDH1A1MEN1KMT2A | |
| SCHEMBL3419160 | 0.92 | LDHA (0.66) | LDHAFPR2ALDH1A1MEN1KMT2A | |
| SCHEMBL2516037 | 0.92 | LDHA (0.66) | LDHAFPR2ALDH1A1MEN1KMT2A | |
| Water SCHEMBL9352790 | 0.91 | LDHA (0.64) | LDHAFPR2ALDH1A1MEN1KMT2A | |
| SCHEMBL6659765 | 0.90 | PTGS1 (0.53) | LDHAPTGS1ALDH1A1MEN1KMT2A | |
| SCHEMBL6659770 | 0.90 | PTGS1 (0.53) | LDHAPTGS1ALDH1A1MEN1KMT2A | |
| Alanine SCHEMBL18301528 | 0.86 | LDHA (0.58) | LDHAFPR2ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0257920-B1 | PROCESS FOR L-DOPA | MERCK & CO. INC. (US) | 1990-10-31 | — | — | EP | claimed |
| EP-0257920-A1 | Process for L-dopa | MERCK & CO. INC. (US) | 1988-03-02 | — | — | EP | claimed |
| US-4716246-A | Process for L-dopa | MERCK & CO., INC. (US) | 1987-12-29 | — | — | US | claimed |
| US-4005127-A | L-Dopa process and intermediates | MONSANTO COMPANY (US) | 1977-01-25 | — | — | US | claimed |
| EP-0257920-B1 | PROCESS FOR L-DOPA | MERCK & CO. INC. (US) | 1990-10-31 | — | — | EP | disclosed |
| EP-0158875-B1 | CHIRAL-RHODIUM-DIPHOSPHINE COMPLEXES FOR ASYMETRIC HYDROGENATIONS | F. HOFFMANN-LA ROCHE AG (CH) | 1989-12-13 | — | — | EP | disclosed |
| EP-0257920-A1 | Process for L-dopa | MERCK & CO. INC. (US) | 1988-03-02 | — | — | EP | disclosed |
| US-4716246-A | Process for L-dopa | MERCK & CO., INC. (US) | 1987-12-29 | — | — | US | disclosed |
| US-4652657-A | Chiral rhodium-diphosphine complexes | HOFFMANN-LA ROCHE INC. (US) | 1987-03-24 | — | — | US | disclosed |
| EP-0158875-A2 | Chiral-rhodium-diphosphine complexes for asymetric hydrogenations | F. HOFFMANN-LA ROCHE AG (CH) | 1985-10-23 | — | — | EP | disclosed |